To P or not to P. That is the wrong question.
Bleeding, Thrombosis and Vascular Biology · Published 2026-06-10 · DOI 10.4081/btvb.2026.572
Free full text
Authors (2)
Augusto Di Castelnuovo, Giovanni De Gaetano
Abstract
A few years ago, an article in the first issue of Bleeding, Thrombosis and Vascular Biology, argued that biomedical research should move beyond the mechanical use of the p-value. That message was not new, but it was timely. It remains timely today. The p-value is still often treated as a gatekeeper: below 0.05, a finding is “real”; above 0.05, it is “negative”. This habit is simple, familiar, and convenient. It is also misleading [...]
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Castelnuovo, A., Gaetano, G. (2026). To P or not to P. That is the wrong question.. Bleeding, Thrombosis and Vascular Biology. https://doi.org/10.4081/btvb.2026.572
Related articles
- In this issue · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Development of a shared decision-making tool for gene therapy in hemophilia A in Italy · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Hormones, cancer, and thrombosis: sex-specific mechanisms at the interface of hemostasis and vascular biology · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Platelet-derived thromboxane A2 induces cyclooxygenase-2 and epithelial-mesenchymal transition marker genes in U-87MG human glioblastoma cells · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Availability of direct oral anticoagulants testing among Italian anticoagulation clinics: a rapid evolution of clinical practice · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Pharmacokinetic interactions between anticancer drugs and direct oral anticoagulants: clinical implications for safe anticoagulation · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Thromboprophylaxis in primary brain cancer · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Efficacy, safety and surgical management with concizumab prophylaxis in three young patients affected by severe hemophilia with inhibitors · Bleeding, Thrombosis and Vascular Biology · 2025 · Same journal
- Factor XI inhibitors in cancer-associated venous thromboembolism: what’s next? · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Bleeding and thrombosis in patients receiving chimeric antigen receptor T-cell therapy · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal